Endoscopically removed malignant colorectal polyps are early stage cancers for which treatment depends on histopathologic findings. For accurate pathologic evaluation, the polyps should be received in 1 piece because margins cannot be accurately assessed in fragmented polyps. Polyps with grade I or II cancer, no lymphovascular invasion, and a negative resection margin can be successfully treated with endoscopic polypectomy, whereas those with grade III cancer, lymphovascular invasion, or a positive or close margin require definitive surgical resection after endoscopic polypectomy. Potentially new significant parameters for patient management are depth of invasion and tumor budding. The pathology report must be clear and concise, indicating all relevant important parameters. The pathologist must differentiate invasive adenocarcinoma from intramucosal adenocarcinoma and pseudo-invasion.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Correspondence: Harry S. Cooper, MD, Department of Pathology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. E-mail: firstname.lastname@example.org
BondJH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol2000;95:3053–3063.
EngstromPFArnolettiJPBensonABIII. The NCCN colon cancer clinical practice guidelines in oncology version 12007. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed 11 September 2007.
EngstromPFArnolettiJPBensonABIII. The NCCN rectal cancer clinical practice guidelines in oncology version 12007. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed 11 September 2007.